Exome analysis of Smith–Magenis-like syndrome cohort identifies de novo likely pathogenic variants
- 813 Downloads
Smith–Magenis syndrome (SMS), a neurodevelopmental disorder characterized by dysmorphic features, intellectual disability (ID), and sleep disturbances, results from a 17p11.2 microdeletion or a mutation in the RAI1 gene. We performed exome sequencing on 6 patients with SMS-like phenotypes but without chromosomal abnormalities or RAI1 variants. We identified pathogenic de novo variants in two cases, a nonsense variant in IQSEC2 and a missense variant in the SAND domain of DEAF1, and candidate de novo missense variants in an additional two cases. One candidate variant was located in an alpha helix of Necdin (NDN), phased to the paternally inherited allele. NDN is maternally imprinted within the 15q11.2 Prader–Willi Syndrome (PWS) region. This can help clarify NDN’s role in the PWS phenotype. No definitive pathogenic gene variants were detected in the remaining SMS-like cases, but we report our findings for future comparison. This study provides information about the inheritance pattern and recurrence risk for patients with identified variants and demonstrates clinical and genetic overlap of neurodevelopmental disorders. Identification and characterization of ID-related genes that assist in development of common developmental pathways and/or gene-networks, may inform disease mechanism and treatment strategies.
KeywordsIntellectual Disability Intellectual Disability Exome Sequencing Missense Variant Exome Analysis
We thank the SMS-like patients and their families for participating in this study. The authors appreciate the support of Settara C Chandrasekharappa, Ph.D., and the Genomics Core of the National Human Genome Research Institute, NIH. This study was partially supported by an NIH Bench to Bedside award (to ACM Smith) and by the Intramural Research Program of the National Human Genome Research Institute, NIH, Bethesda, Maryland, USA.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethics standards.
- Beneduzzi D, Iyer AK, Trarbach EB, Silveira-Neto AP, Silveira LG, Tusset C, Yip K, Mendonca BB, Mellon PL, Latronico AC (2011) Mutational analysis of the necdin gene in patients with congenital isolated hypogonadotropic hypogonadism. Eur J Endocrinol 165:145–150. doi: 10.1530/EJE-11-0199 CrossRefPubMedPubMedCentralGoogle Scholar
- Bodian DL, Solomon BD, Khromykh A, Thach DC, Iyer RK, Link K, Baker RL, Baveja R, Vockley JG, Niederhuber JE (2014) Diagnosis of an imprinted-gene syndrome by a novel bioinformatics analysis of whole-genome sequences from a family trio. Mol Genet Genomic Med 2:530–538. doi: 10.1002/mgg3.107 CrossRefPubMedPubMedCentralGoogle Scholar
- Chen L, Jensik P, Walkiewicz M, Alaimo JT, Mullegama SV, Elsea SH (2015) Functional characterization of novel DEAF1 mutations in clinical whole-exome sequencing of intellectual disability patients and its regulation of the RAI1 gene; (Program#387). In: Presented at the 65th Annual Meeting of The American Society of Human Genetics, Baltimore, MD, October 10, 2015Google Scholar
- Clayton-Smith J, O’Sullivan J, Daly S et al (2011) Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome. Am J Hum Genet 89:675–681. doi: 10.1016/j.ajhg.2011.10.008 CrossRefPubMedPubMedCentralGoogle Scholar
- Driscoll DJ, Miller JL, Schwartz S, Cassidy SB (1993) Prader–Willi Syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH (eds) Gene Reviews (R). University of Washington, Seattle, WAGoogle Scholar
- Miller DT, Adam MP, Aradhya S et al (2010) Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86:749–764. doi: 10.1016/j.ajhg.2010.04.006 CrossRefPubMedPubMedCentralGoogle Scholar
- Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17:405–424. doi: 10.1038/gim.2015.30 CrossRefPubMedPubMedCentralGoogle Scholar
- Smith ACM, Boyd KE, Elsea SH, Finucane BM, Haas-Givler B, Gropman A, Laje G, Magenis E, Potocki L. (2012) Smith-Magenis Syndrome Seattle (WA): University of Washington, Seattle; 2001 . Available from: https://www.ncbi.nlm.nih.gov/books/NBK1310/. Accessed 28 Jun 2012
- Vilboux T, Ciccone C, Blancato JK, Cox GF, Deshpande C, Introne WJ, Gahl WA, Smith ACM, Huizing M (2011) Molecular analysis of the retinoic acid induced 1 Gene (RAI1) in patients with suspected Smith-Magenis syndrome without the 17p11.2 deletion. PLoS One 6:14. doi: 10.1371/journal.pone.0022861 CrossRefGoogle Scholar
- Zanella S, Watrin F, Mebarek S, Marly F, Roussel M, Gire C, Diene G, Tauber M, Muscatelli F, Hilaire G (2008) Necdin plays a role in the serotonergic modulation of the mouse respiratory network: implication for Prader–Willi syndrome. J Neurosci 28:1745–1755. doi: 10.1523/JNEUROSCI.4334-1707.2008 CrossRefPubMedGoogle Scholar